Guidance for Novavax, Inc. (NVAX)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2025 | N/A | N/A | $1.00B – 1.05B | $1.02B | = Maintained | Details |
| 2025 | N/A | N/A | $975.00M – 1025.00M | N/A | = Maintained | Details |
| Q3 2025 | N/A | N/A | $495.00M – 545.00M | $89.61M | = Maintained | Details |
| 2024 | N/A | N/A | $650.00M – 700.00M | $761.50M | = Maintained | Details |
| 2024 | N/A | N/A | $0.80B – 1.00B | $0.97B | = Maintained | Details |
| Q2 2024 | N/A | N/A | $800.00B – 1.00B | $845.50B | = Maintained | Details |
| 2023 | N/A | N/A | $1400.00M – 1600.00M | $831.06M | = Maintained | Details |
| 2022 | N/A | N/A | $2.00B | $2.04B |  Lowered |
Details |
| 2022 | N/A | N/A | $2.00B – 2.30B | $4.27B | Lowered |
Details |
| 2022 | N/A | N/A | $4.00B – 5.00B | N/A | = Maintained | Details |
| 2022 | N/A | N/A | $4.00M – 5.00M | N/A | = Maintained | Details |
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
